In vitro activity of guinea pig transfer factor released into plasma.
Plasma fractions and plasma dialysate from 2,4-dinitrochlorobenzene- and tuberculin-sensitive guinea pigs that had been treated with either antilymphocytic serum or normal control serum were analyzed for their ability to transfer lymphocyte transformation, passive cutaneous anaphylaxis, and macrophage migration inhibition, as well as delayed hypersensitivity in vivo. Antilymphocytic serum caused rapid release of material, which has characteristics of transfer factor, into the plasma. It was dialyzable, migrated electrophoretically with the alpha globulins and albumin, possessed a 280/260 (nm) optical density ratio of 0.7, and caused in vitro lymphocyte transformation in the presence of the specific antigen. Passive cutaneous anaphylaxis antibodies were also present in the plasma of sensitive animals, but they were isolated in electrophoretic or dialysis fractions separate from those containing transfer activity.
D000418:Albumins; D000818:Animals; D000961:Antilymphocyte Serum / Q000494:pharmacology; D002464:Cell Migration Inhibition; D004137:Dinitrochlorobenzene; D005260:Female; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed; D007106:Immune Sera / Q000494:pharmacology; D007112:Immunity, Maternally-Acquired; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D008297:Male; D010323:Passive Cutaneous Anaphylaxis; D010949:Plasma / Q000276:immunology*; D014373:Tuberculin
D000418:Albumins; D000961:Antilymphocyte Serum; D004137:Dinitrochlorobenzene; D007106:Immune Sera; D014373:Tuberculin